Literature DB >> 7589164

CB-64D and CB-184: ligands with high sigma 2 receptor affinity and subtype selectivity.

W D Bowen1, C M Bertha, B J Vilner, K C Rice.   

Abstract

Four members of a novel class of sigma (sigma) ligands were investigated for sigma subtype selectivity. (-)-1S,5S- and (+)-1R,5R-(E)-8-Benzylidene-5-(3-hydroxyphenyl)-2-methylmorphan-7- one (CB-64L and CB-64D, respectively) exhibited sigma 1 Ki = 10.5 nM and 3063 nM; sigma 2 Ki = 154 nM and 16.5 nM, respectively. The corresponding 3,4-dichloro derivatives, (-)-1S,5S- and (+)-1R,5R-(E)-8-(3,4-dichlorobenzylidene)-5-(3-hydroxyphenyl)-2-++ +methylmorphan-7 - one (CB-182 and CB-184, respectively) were also examined. CB-182 ((-)-isomer) showed sigma 1 and sigma 2 Ki = 27.3 nM and 35.5 nM, respectively, whereas CB-184 ((+)-isomer) exhibited sigma 1 and sigma 2 Ki = 7436 nM and 13.4 nM, respectively. Thus, the two sigma subtypes showed opposite enantioselectivity for these compounds, with (-) > (+) at sigma 1 and (+) > (-) at sigma 2. Importantly, CB-64D and CB-184 showed high sigma 2 affinity and, respectively, 185-fold and 554-fold selectivity for sigma 2 receptors over sigma 1. While high sigma 2 selectivity relative to sigma 1 was achieved with these compounds, they both exhibited high affinity at mu (mu) opioid receptors (Ki = 37.6 nM and 4.5 nM, respectively). Despite this, CB-64D and CB-184 will be useful tools for further characterization of sigma 2 receptors.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7589164     DOI: 10.1016/0014-2999(95)00176-l

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  15 in total

Review 1.  Sigma receptors: biology and therapeutic potential.

Authors:  Xavier Guitart; Xavier Codony; Xavier Monroy
Journal:  Psychopharmacology (Berl)       Date:  2004-06-10       Impact factor: 4.530

Review 2.  Development of molecular probes for imaging sigma-2 receptors in vitro and in vivo.

Authors:  Robert Henry Mach; Kenneth Theodore Wheeler
Journal:  Cent Nerv Syst Agents Med Chem       Date:  2009-09

3.  Characterization of CM572, a Selective Irreversible Partial Agonist of the Sigma-2 Receptor with Antitumor Activity.

Authors:  Hilary Nicholson; Anthony Comeau; Christophe Mesangeau; Christopher R McCurdy; Wayne D Bowen
Journal:  J Pharmacol Exp Ther       Date:  2015-06-01       Impact factor: 4.030

4.  Electron-donating para-methoxy converts a benzamide-isoquinoline derivative into a highly Sigma-2 receptor selective ligand.

Authors:  Abdol R Hajipour; Lian-Wang Guo; Arindam Pal; Timur Mavlyutov; Arnold E Ruoho
Journal:  Bioorg Med Chem       Date:  2011-10-20       Impact factor: 3.641

5.  Functional assays to define agonists and antagonists of the sigma-2 receptor.

Authors:  Chenbo Zeng; Justin M Rothfuss; Jun Zhang; Suwanna Vangveravong; Wenhua Chu; Shihong Li; Zhude Tu; Jinbin Xu; Robert H Mach
Journal:  Anal Biochem       Date:  2013-12-12       Impact factor: 3.365

6.  Effects of UMB24 and (+/-)-SM 21, putative sigma2-preferring antagonists, on behavioral toxic and stimulant effects of cocaine in mice.

Authors:  Rae R Matsumoto; Buddy Pouw; Aisha L Mack; Antawan Daniels; Andrew Coop
Journal:  Pharmacol Biochem Behav       Date:  2006-12-22       Impact factor: 3.533

Review 7.  The σ2 receptor: a novel protein for the imaging and treatment of cancer.

Authors:  Robert H Mach; Chenbo Zeng; William G Hawkins
Journal:  J Med Chem       Date:  2013-06-18       Impact factor: 7.446

8.  New N-substituted 9-azabicyclo[3.3.1]nonan-3alpha-yl phenylcarbamate analogs as sigma2 receptor ligands: synthesis, in vitro characterization, and evaluation as PET imaging and chemosensitization agents.

Authors:  Wenhua Chu; Jinbin Xu; Dong Zhou; Fanjie Zhang; Lynne A Jones; Kenneth T Wheeler; Robert H Mach
Journal:  Bioorg Med Chem       Date:  2008-12-24       Impact factor: 3.641

9.  Synthesis and structure-activity relationship studies of conformationally flexible tetrahydroisoquinolinyl triazole carboxamide and triazole substituted benzamide analogues as σ2 receptor ligands.

Authors:  Suping Bai; Shihong Li; Jinbin Xu; Xin Peng; Kiran Sai; Wenhua Chu; Zhude Tu; Chenbo Zeng; Robert H Mach
Journal:  J Med Chem       Date:  2014-05-12       Impact factor: 7.446

10.  Recent Advances in the Development of Sigma Receptor Ligands as Cytotoxic Agents: A Medicinal Chemistry Perspective.

Authors:  Antonino N Fallica; Valeria Pittalà; Maria N Modica; Loredana Salerno; Giuseppe Romeo; Agostino Marrazzo; Mohamed A Helal; Sebastiano Intagliata
Journal:  J Med Chem       Date:  2021-06-02       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.